Production (Stage)
Inspire Veterinary Partners, Inc.
IVP
$1.48
-$0.08-5.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -24.68% | -12.23% | -1.71% | -2.21% | 12.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -24.68% | -12.23% | -1.71% | -2.21% | 12.82% |
| Cost of Revenue | -21.49% | -23.48% | 11.87% | 4.09% | 16.88% |
| Gross Profit | -35.42% | 276.48% | -40.93% | -18.40% | 1.01% |
| SG&A Expenses | -14.86% | 52.74% | -16.11% | 17.65% | 59.48% |
| Depreciation & Amortization | -25.00% | -22.69% | 8.59% | 12.14% | 23.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.94% | 3.60% | -2.65% | 9.26% | 31.74% |
| Operating Income | 5.95% | -28.74% | 4.01% | -64.42% | -112.38% |
| Income Before Tax | 29.42% | 4.23% | 55.74% | -175.84% | -122.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.42% | 4.23% | 55.74% | -175.84% | -122.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.42% | 4.23% | 55.74% | -175.84% | -122.35% |
| EBIT | 5.95% | -28.74% | 4.01% | -64.42% | -112.38% |
| EBITDA | 3.07% | -34.82% | 5.59% | -89.71% | -152.94% |
| EPS Basic | 50.53% | -- | -- | -- | -- |
| Normalized Basic EPS | 37.15% | -- | -- | -- | -- |
| EPS Diluted | 50.53% | -- | -- | -- | -- |
| Normalized Diluted EPS | 37.15% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 42.62% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 42.62% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |